Table 2.
Antiviral activity of compound 1 analogs modified at the thiophenyl ringa
|
| |||||
|---|---|---|---|---|---|
| compd | R4 | R6 | R3’ | R4’ | IC50 |
| 18 | H | Me | H | H | NA |
| 18a | H | Me | Cl | H | 51 |
| 18b | H | Me | F | H | 69 |
| 18c | H | Me | H | Br | NA |
| 18d | H | Me | H | Me | NA |
| 18e | H | Me | H | OMe | NA |
| 18f | H | Me | H | CO2H | NA |
| 18g | H | Me | H | CF3 | 33 |
| 19 | Me | H | H | OMe | NA |
| 19a | Me | H | H | Me | NA |
| 19b | Me | H | H | CO2Me | NA |
| 19c | Me | H | H | NO2 | NA |
IC50 values were determined from triplicate measurements and repeated at least twice. Values ≥ 100 µM were designated as not active (NA).